Real-World Treatment Outcomes of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Children Aged Less than 12 years: 2-year Results from PEDISTAD (February JAAD)
March 24, 2025

Atopic dermatitis (AD) remains one of the most prevalent and challenging dermatologic conditions to treat in pediatric patients. On this month’s JAAD episode, Charles Dunn, MD sits down Annie Zhang, MD to discuss her group’s recently published article outlining 2-year interim results from the PEDIatric STudy in Atopic Dermatitis (PEDISTAD).
Summary
Availability:
On-Demand
Expires on Mar 24, 2028
Credit Offered:
0.5 CME Credit
Recommended

Legal notice
Copyright © 2026 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
Android App Download IOS App Download Powered By